Everyone has heard the talk. Pfizer (PFE) is getting ready to make a deal. the skinny on Wall Street is that the U.S. pharmaceutical giant has its eyes set on rival Bristol-Myers Squibb (BMY) and its immuno-oncology business. Bloomberg News But Alex Arfaei, the pharma industry analyst at BMO Capital Markets, says a marriage with biotech […]